<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Buckley, Rita</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Marso, Steven P.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">IV Exenatide Has the Same Efficacy as Insulin in C ICU Patients, without Inducing Hypoglycemia</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2011</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2011-08-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">10-11</style></pages><abstract><style  face="normal" font="default" size="100%">Intravenous (IV) insulin is currently the standard of care but requires frequent monitoring and can cause excess hypoglycemia. This article presents results from a pilot study to determine the feasibility, efficacy, and safety of IV exenatide in hyperglycemic cardiac intensive care unit patients [Intravenous Exenatide in Coronary Intensive Care Unit Patients; NCT00736229].</style></abstract><number><style face="normal" font="default" size="100%">8</style></number><volume><style face="normal" font="default" size="100%">11</style></volume></record></records></xml>